Anito-cel for Multiple Myeloma

Anito-cel is a new therapeutic option for the treatment of multiple myeloma. The study was published in the New England Journal of Medicine in September 2026. Multiple myeloma is a serious oncological disease affecting the bone marrow. Anito-cel represents an innovative approach in the treatment of this disease. The research was published in the 12th issue of volume 395 of a renowned medical journal. This therapy opens new possibilities for patients diagnosed with multiple myeloma.